Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeting KRAS in Non-Small Cell Lung Cancer.
Corral de la Fuente E, Olmedo Garcia ME, Gomez Rueda A, Lage Y, Garrido P. Corral de la Fuente E, et al. Front Oncol. 2022 Jan 10;11:792635. doi: 10.3389/fonc.2021.792635. eCollection 2021. Front Oncol. 2022. PMID: 35083149 Free PMC article. Review.
Sarcoidosis-like reactions in cancer patients treated with immune checkpoint inhibitors: experience in a Spanish hospital.
Torres-Jiménez J, Esteban-Villarrubia J, García-Abellás P, Cortés-Salgado A, Soria-Rivas A, Gajate-Borau P, Olmedo-García ME, Corral-de la Fuente E, Lage-Alfranca Y, Gómez-Rueda A, Benito-Berlinches A, Gorospe-Sarasua L, Garrido-López P. Torres-Jiménez J, et al. Among authors: corral de la fuente e. Clin Transl Oncol. 2021 Jul;23(7):1474-1480. doi: 10.1007/s12094-020-02546-w. Epub 2021 Jan 12. Clin Transl Oncol. 2021. PMID: 33433837
Anti-Zic4 paraneoplastic cerebellar degeneration in a patient with EGFR-mutated NSCLC: a case report.
Pozas J, Albarrán-Fernández V, González-Campo L, Olmedo-García ME, Corral de la Fuente E, Corral-Corral I, Carrasco Á, Alonso-Gordoa T, Molina-Cerrillo J, Lage-Alfranca Y, Gómez-Rueda A, Garrido P. Pozas J, et al. Among authors: corral de la fuente e. Transl Lung Cancer Res. 2022 Jul;11(7):1497-1502. doi: 10.21037/tlcr-21-989. Transl Lung Cancer Res. 2022. PMID: 35958343 Free PMC article.
Prolonged Responses With Trastuzumab Emtasine Treatment of Human Epidermal Growth Factor Receptor 2-positive Metastatic Breast Cancer Refractory to Trastuzumab and Pertuzumab: Systematic Review of Evidence.
Martin Huertas R, Fernández Abad M, Corral de la Fuente E, Serrano Domingo JJ, Martínez Jáñez N. Martin Huertas R, et al. Among authors: corral de la fuente e. Clin Breast Cancer. 2021 Oct;21(5):391-398. doi: 10.1016/j.clbc.2021.01.004. Epub 2021 Jan 7. Clin Breast Cancer. 2021. PMID: 33549470
Analysis of adverse drug events as a way to improve cancer patient care.
Vicente-Oliveros N, Gramage-Caro T, Corral de la Fuente E, Delgado-Silveira E, Álvarez-Díaz AM. Vicente-Oliveros N, et al. Among authors: corral de la fuente e. Eur J Hosp Pharm. 2023 Dec 27;31(1):27-30. doi: 10.1136/ejhpharm-2021-003199. Eur J Hosp Pharm. 2023. PMID: 35332064 Free PMC article.
MYC targeting by OMO-103 in solid tumors: a phase 1 trial.
Garralda E, Beaulieu ME, Moreno V, Casacuberta-Serra S, Martínez-Martín S, Foradada L, Alonso G, Massó-Vallés D, López-Estévez S, Jauset T, Corral de la Fuente E, Doger B, Hernández T, Perez-Lopez R, Arqués O, Castillo Cano V, Morales J, Whitfield JR, Niewel M, Soucek L, Calvo E. Garralda E, et al. Among authors: corral de la fuente e. Nat Med. 2024 Mar;30(3):762-771. doi: 10.1038/s41591-024-02805-1. Epub 2024 Feb 6. Nat Med. 2024. PMID: 38321218 Free PMC article. Clinical Trial.
11 results